A new trading day began on Monday, with Checkpoint Therapeutics Inc (NASDAQ: CKPT) stock price down -5.84% from the previous day of trading, before settling in for the closing price of $2.57. CKPT’s price has ranged from $1.30 to $3.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -47.67%. Meanwhile, its annual earnings per share averaged 60.15%. With a float of $30.34 million, this company’s outstanding shares have now reached $38.08 million.
The extent of productivity of a business whose workforce counts for 23 workers is very important to gauge.
Checkpoint Therapeutics Inc (CKPT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Checkpoint Therapeutics Inc is 20.34%, while institutional ownership is 14.61%. The most recent insider transaction that took place on Jun 26 ’24, was worth 50,450. In this transaction CEO, President and Director of this company sold 24,610 shares at a rate of $2.05, taking the stock ownership to the 1,977,170 shares. Before that another transaction happened on Jun 26 ’24, when Company’s Chief Financial Officer sold 13,038 for $2.06, making the entire transaction worth $26,858. This insider now owns 672,186 shares in total.
Checkpoint Therapeutics Inc (CKPT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 60.15% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
Here are Checkpoint Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1316.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
The latest stats from [Checkpoint Therapeutics Inc, CKPT] show that its last 5-days average volume of 0.69 million was superior to 0.48 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 36.67%. Additionally, its Average True Range was 0.19.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 72.73%, which indicates a significant increase from 40.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.58% in the past 14 days, which was higher than the 60.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.12, while its 200-day Moving Average is $2.03. Now, the first resistance to watch is $2.57. This is followed by the second major resistance level at $2.73. The third major resistance level sits at $2.81. If the price goes on to break the first support level at $2.33, it is likely to go to the next support level at $2.25. The third support level lies at $2.09 if the price breaches the second support level.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
With a market capitalization of 92.15 million, the company has a total of 35,686K Shares Outstanding. Currently, annual sales are 100 K while annual income is -51,850 K. The company’s previous quarter sales were 10 K while its latest quarter income was -19,130 K.
